Betül Çiğdem Yortanlı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Betül Çiğdem Yortanlı has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Yortanlı
Department of Emergency Medicine, Konya Numune Hospital, Konya, Turkiye
9 shared publications - Korhan Kollu
Konya Şehir Hastanesi
6 shared publications - Muhammet Cemal Kizilarslanoglu
Hamidiye School of Medicine, Konya City Hospital, Department of Internal Medicine, Division of Geriatrics University of Health Sciences Türkiye Konya Türkiye
5 shared publications - Ekrem Taha Sert
Department of Emergency Medicine, Aksaray University Medical School, Aksaray, Turkey
3 shared publications - Hüseyin Mutlu
Department of Emergency Medicine, Faculty of Medicine, Aksaray University, Aksaray, Turkey
3 shared publications - Selma Özlem Çelikdelen
Hamidiye School of Medicine, Konya City Hospital, Department of Internal Medicine University of Health Sciences Türkiye Konya Türkiye
3 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
Lactate-to-Albumin Ratio for Predicting Post-Contrast Acute Kidney Injury After Contrast-Enhanced CT in the Emergency Department
Clinical and Experimental Emergency Medicine
- 27 July 2026
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
Open AccessLactate-to-Albumin Ratio for Predicting Post-Contrast Acute Kidney Injury After Contrast-Enhanced CT in the Emergency Department
Clinical and Experimental Emergency Medicine
- Open Access
- 6 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2428
Serum Cocaine- and Amphetamine-Regulated Transcript (CART) Levels in Graves’ Disease: Associations with Metabolic Status, Autoimmunity, and Thyroid Ultrasound Heterogeneity
Graves’ disease (GD) is an autoimmune disorder characterized by hyperthyroidism and a hypermetabolic state involving complex endocrine, metabolic, and immune interactions. Cocaine- and amphetamine-regulated transcript (CART) is a neuropeptide involved in energy balance, neuroendocrine signaling, and neuroimmune modulation; however, its circulating levels and clinical relevance in GD remain unclear. In this single-center prospective study, serum CART levels were evaluated in 44 patients with GD and 44 age- and sex-matched healthy controls. Associations with thyroid function, autoimmune markers, metabolic parameters, and thyroid ultrasound heterogeneity were analyzed. Serum CART concentrations were measured using an enzyme-linked immunosorbent assay, and clinical, biochemical, and ultrasonographic data were recorded. Serum CART levels did not differ significantly between GD patients and healthy controls. However, within the GD group, CART levels varied significantly according to thyroid ultrasound heterogeneity, with lower levels observed in patients with severe parenchymal heterogeneity. Serum CART levels showed positive correlations with body mass index and insulin resistance indices, while inverse correlations were observed with thyrotropin receptor antibody and anti-thyroid peroxidase antibody levels. No significant associations were identified between serum CART levels and circulating thyroid hormone concentrations. These findings suggest that serum CART may reflect metabolic and autoimmune heterogeneity rather than hypothalamic–pituitary–thyroid axis activity in GD, supporting its role as a context-sensitive, hypothesis-generating biomarker.
- 6 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2428
Open AccessSerum Cocaine- and Amphetamine-Regulated Transcript (CART) Levels in Graves’ Disease: Associations with Metabolic Status, Autoimmunity, and Thyroid Ultrasound Heterogeneity
Graves’ disease (GD) is an autoimmune disorder characterized by hyperthyroidism and a hypermetabolic state involving complex endocrine, metabolic, and immune interactions. Cocaine- and amphetamine-regulated transcript (CART) is a neuropeptide involved in energy balance, neuroendocrine signaling, and neuroimmune modulation; however, its circulating levels and clinical relevance in GD remain unclear. In this single-center prospective study, serum CART levels were evaluated in 44 patients with GD and 44 age- and sex-matched healthy controls. Associations with thyroid function, autoimmune markers, metabolic parameters, and thyroid ultrasound heterogeneity were analyzed. Serum CART concentrations were measured using an enzyme-linked immunosorbent assay, and clinical, biochemical, and ultrasonographic data were recorded. Serum CART levels did not differ significantly between GD patients and healthy controls. However, within the GD group, CART levels varied significantly according to thyroid ultrasound heterogeneity, with lower levels observed in patients with severe parenchymal heterogeneity. Serum CART levels showed positive correlations with body mass index and insulin resistance indices, while inverse correlations were observed with thyrotropin receptor antibody and anti-thyroid peroxidase antibody levels. No significant associations were identified between serum CART levels and circulating thyroid hormone concentrations. These findings suggest that serum CART may reflect metabolic and autoimmune heterogeneity rather than hypothalamic–pituitary–thyroid axis activity in GD, supporting its role as a context-sensitive, hypothesis-generating biomarker.
- Open Access
- 20 February 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (1) , 168-174
Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis
Aims: This study aimed to evaluate the prognostic performance of the age–male–albumin–bilirubin–platelet (aMAP) score in predicting 28-day mortality among patients with acute pancreatitis (AP) presenting to the emergency department (ED).Methods: We retrospectively analyzed adult patients diagnosed with AP between January 2020 and December 2024 in a tertiary ED. Demographic characteristics, laboratory findings, clinical parameters, and mortality outcomes were recorded. aMAP scores were calculated using a validated formula. The prognostic performance of the aMAP score was compared with that of ALBI, BISAP, SOFA, and lactate levels using logistic regression and ROC curve analysis. Results: A total of 386 patients were included in the analysis. The median age was significantly higher among non-survivors than survivors (77 vs. 60 years, p
- 20 February 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (1) , 168-174
Open AccessAge-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis
Aims: This study aimed to evaluate the prognostic performance of the age–male–albumin–bilirubin–platelet (aMAP) score in predicting 28-day mortality among patients with acute pancreatitis (AP) presenting to the emergency department (ED).Methods: We retrospectively analyzed adult patients diagnosed with AP between January 2020 and December 2024 in a tertiary ED. Demographic characteristics, laboratory findings, clinical parameters, and mortality outcomes were recorded. aMAP scores were calculated using a validated formula. The prognostic performance of the aMAP score was compared with that of ALBI, BISAP, SOFA, and lactate levels using logistic regression and ROC curve analysis. Results: A total of 386 patients were included in the analysis. The median age was significantly higher among non-survivors than survivors (77 vs. 60 years, p
- Open Access
- 14 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1845
Spexin as a Novel Biomarker for Predicting Disease Severity and Mortality in Acute Pancreatitis
This study aimed to investigate the diagnostic and prognostic value of serum spexin levels in patients with acute pancreatitis (AP) and to assess their association with disease severity and mortality. A total of 34 AP patients and 34 healthy individuals were included in the study. AP patients were classified into three groups: mild, moderately severe, and severe (SAP). Serum spexin levels were measured using ELISA, and biochemical parameters, inflammatory indices, and clinical scores were compared. Univariate logistic regression analysis was performed to evaluate factors associated with AP severity and mortality, and ROC analysis was used to assess the diagnostic performance. The median spexin level in AP patients was significantly higher than in healthy controls (p < 0.001). Spexin levels increased markedly in SAP patients and were highest in non-survivors (p < 0.001). In univariate analysis, higher spexin levels were associated with SAP (OR: 4.116, 95% CI: 1.348–12.572; p = 0.013) and 28-day mortality (OR: 3.132, 95% CI: 1.316–7.453; p = 0.010). ROC analyses suggested favorable diagnostic performance of spexin; however, given the exploratory design and small sample size, the findings should be interpreted with caution. Spexin may serve as a complementary early-phase biomarker for risk stratification.
- 14 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1845
Open AccessSpexin as a Novel Biomarker for Predicting Disease Severity and Mortality in Acute Pancreatitis
This study aimed to investigate the diagnostic and prognostic value of serum spexin levels in patients with acute pancreatitis (AP) and to assess their association with disease severity and mortality. A total of 34 AP patients and 34 healthy individuals were included in the study. AP patients were classified into three groups: mild, moderately severe, and severe (SAP). Serum spexin levels were measured using ELISA, and biochemical parameters, inflammatory indices, and clinical scores were compared. Univariate logistic regression analysis was performed to evaluate factors associated with AP severity and mortality, and ROC analysis was used to assess the diagnostic performance. The median spexin level in AP patients was significantly higher than in healthy controls (p < 0.001). Spexin levels increased markedly in SAP patients and were highest in non-survivors (p < 0.001). In univariate analysis, higher spexin levels were associated with SAP (OR: 4.116, 95% CI: 1.348–12.572; p = 0.013) and 28-day mortality (OR: 3.132, 95% CI: 1.316–7.453; p = 0.010). ROC analyses suggested favorable diagnostic performance of spexin; however, given the exploratory design and small sample size, the findings should be interpreted with caution. Spexin may serve as a complementary early-phase biomarker for risk stratification.
- Open Access
- 27 January 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Lactate clearance predicts massive transfusion in upper gastrointestinal bleeding: a single-center retrospective study
Lactate clearance (LC) has emerged as a potential prognostic marker in critically ill patients. However, its role in predicting massive transfusion (MT) re
- 27 January 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessLactate clearance predicts massive transfusion in upper gastrointestinal bleeding: a single-center retrospective study
Lactate clearance (LC) has emerged as a potential prognostic marker in critically ill patients. However, its role in predicting massive transfusion (MT) re
- Open Access
- 21 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1)
Predicting Adverse Outcomes via Simple Assessment Tools Among Older Inpatients With Nonsevere COVID‐19: The SARC‐F Score, FRAIL Scale, and G8 Questionnaire
Purpose: To investigate the predictive ability of the SARC‐F score, FRAIL scale, and G8 questionnaire on adverse clinical outcomes in older inpatients with COVID‐19. Methods: A total of 141 patients (50.4% male) were included in this prospective cohort study and assessed by the SARC‐F score (for sarcopenia risk), FRAIL scale (for frailty status), and G8 questionnaire (for vulnerability risk) on the first day of hospitalization. The outcomes, including length of stay (LOS), need for intensive care unit (ICU) admission (NICUA), and mortality, were recorded. Results: Median age was 71 years (median LOS, 9 days; NICUA, 15.6%; and in‐hospital mortality, 2.8%). The patients’ frailty, sarcopenia risk, and vulnerability rates were 43.3%, 37.6%, and 52.5%, respectively. Crude regression models showed that sarcopenia risk (odds ratio (OR): 10.800; p < 0.001), frailty (OR: 4.385; p = 0.002), and vulnerability (OR: 12.037; p < 0.001) might be related factors for the NICUA. All scales showed good predictive performance in ROC curve analyses. For predicting the need for intensive care unit admission, the AUC values were 0.696 for the FRAIL scale, 0.769 for the SARC–F‐score, and 0.785 for the G8 questionnaire. For in‐hospital mortality, the corresponding AUC values were 0.792, 0.799, and 0.822, respectively (all p < 0.001). Conclusion: This study suggests that the mentioned assessment tools might predict worse clinical outcomes among the study population.
- 21 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1)
Open AccessPredicting Adverse Outcomes via Simple Assessment Tools Among Older Inpatients With Nonsevere COVID‐19: The SARC‐F Score, FRAIL Scale, and G8 Questionnaire
Purpose: To investigate the predictive ability of the SARC‐F score, FRAIL scale, and G8 questionnaire on adverse clinical outcomes in older inpatients with COVID‐19. Methods: A total of 141 patients (50.4% male) were included in this prospective cohort study and assessed by the SARC‐F score (for sarcopenia risk), FRAIL scale (for frailty status), and G8 questionnaire (for vulnerability risk) on the first day of hospitalization. The outcomes, including length of stay (LOS), need for intensive care unit (ICU) admission (NICUA), and mortality, were recorded. Results: Median age was 71 years (median LOS, 9 days; NICUA, 15.6%; and in‐hospital mortality, 2.8%). The patients’ frailty, sarcopenia risk, and vulnerability rates were 43.3%, 37.6%, and 52.5%, respectively. Crude regression models showed that sarcopenia risk (odds ratio (OR): 10.800; p < 0.001), frailty (OR: 4.385; p = 0.002), and vulnerability (OR: 12.037; p < 0.001) might be related factors for the NICUA. All scales showed good predictive performance in ROC curve analyses. For predicting the need for intensive care unit admission, the AUC values were 0.696 for the FRAIL scale, 0.769 for the SARC–F‐score, and 0.785 for the G8 questionnaire. For in‐hospital mortality, the corresponding AUC values were 0.792, 0.799, and 0.822, respectively (all p < 0.001). Conclusion: This study suggests that the mentioned assessment tools might predict worse clinical outcomes among the study population.
- Open Access
- 1 January 2026
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
Association Between Serum PADI‐4 Levels and Disease Activity in Ulcerative Colitis Patients
Objectives: PADI‐4 is a member of the peptidyl arginine deiminase enzyme family. This enzyme is expressed by inflammatory cells and plays an important role in inflammation and immune responses. In this study, we aimed to evaluate serum PADI‐4 levels in patients with ulcerative colitis (UC) and to investigate the relationship between PADI‐4 and disease activity. Material and Method: Fifty‐one patients with UC and 31 healthy controls were included in this observational study. First, serum PADI‐4 levels in patients with UC and the control group were compared. Subsequently, serum PADI‐4 levels were analyzed in UC patients with active disease and those who are in remission, separately. Finally, the impact of PADI‐4 on predicting disease activity was evaluated by performing correlation analyses between serum PADI‐4 and C‐reactive protein (CRP) in addition to the total Mayo score (TMS) and modified Mayo Endoscopic Subscore (MESS). Results: Serum mean PADI‐4 levels were found to be significantly higher in the UC group (1317 ± 818 pg/mL) compared to the control group (873 ± 622 pg/mL) ( p : 0.009). Serum mean PADI‐4 levels were significantly different between the three groups (patients with remission, mild disease, and moderate/severe disease group) ( p : 0.015) (1076 ± 609, 1073 ± 683, and 1802 ± 943 pg/mL, respectively). In Spearman′s correlation analysis, it was determined that there was a positive and significant relationship between PADI‐4 and CRP levels ( r = 0.31, p : 0.027) in addition to TMS ( r = 0.419, p : 0.02) and MESS ( r = 0.417, p : 0.002). The ideal serum PADI‐4 levels for predicting disease activity were found to be 980 pg/mL. Conclusion: Our study revealed that serum PADI‐4 levels were higher in patients with UC compared to healthy controls and might be an effective marker to determine disease severity.
- 1 January 2026
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
Open AccessAssociation Between Serum PADI‐4 Levels and Disease Activity in Ulcerative Colitis Patients
Objectives: PADI‐4 is a member of the peptidyl arginine deiminase enzyme family. This enzyme is expressed by inflammatory cells and plays an important role in inflammation and immune responses. In this study, we aimed to evaluate serum PADI‐4 levels in patients with ulcerative colitis (UC) and to investigate the relationship between PADI‐4 and disease activity. Material and Method: Fifty‐one patients with UC and 31 healthy controls were included in this observational study. First, serum PADI‐4 levels in patients with UC and the control group were compared. Subsequently, serum PADI‐4 levels were analyzed in UC patients with active disease and those who are in remission, separately. Finally, the impact of PADI‐4 on predicting disease activity was evaluated by performing correlation analyses between serum PADI‐4 and C‐reactive protein (CRP) in addition to the total Mayo score (TMS) and modified Mayo Endoscopic Subscore (MESS). Results: Serum mean PADI‐4 levels were found to be significantly higher in the UC group (1317 ± 818 pg/mL) compared to the control group (873 ± 622 pg/mL) ( p : 0.009). Serum mean PADI‐4 levels were significantly different between the three groups (patients with remission, mild disease, and moderate/severe disease group) ( p : 0.015) (1076 ± 609, 1073 ± 683, and 1802 ± 943 pg/mL, respectively). In Spearman′s correlation analysis, it was determined that there was a positive and significant relationship between PADI‐4 and CRP levels ( r = 0.31, p : 0.027) in addition to TMS ( r = 0.419, p : 0.02) and MESS ( r = 0.417, p : 0.002). The ideal serum PADI‐4 levels for predicting disease activity were found to be 980 pg/mL. Conclusion: Our study revealed that serum PADI‐4 levels were higher in patients with UC compared to healthy controls and might be an effective marker to determine disease severity.
- 1 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (4) , 630-636
The Prognostic Role of the D-dimer/Fibrinogen Ratio in Predicting In-hospital Mortality among Sepsis Patients
Aims: Dysregulated coagulation and fibrinolysis are central to sepsis pathobiology. This study evaluated the prognostic value of the D-dimer/fibrinogen ratio (DFR) for in-hospital mortality in patients with sepsis. Methods: We analyzed 130 consecutive sepsis patients. The Sepsis-3 criteria were used to establish the diagnosis of sepsis. Demographic and clinical variables, APACHE II, SOFA, D-dimer, fibrinogen, and DFR were recorded at admission. The association between DFR and in-hospital mortality was assessed using multivariable models alongside APACHE II and SOFA. Discrimination was examined with ROC analysis. Results: Non-survivors had higher APACHE II scores, SOFA scores, and DFR than survivors. In multivariable analysis, increasing APACHE II, SOFA, and DFR were each independent predictors of in-hospital mortality. DFR showed high sensitivity and specificity for mortality on ROC analysis. Demographic features did not correlate with survival. Conclusion: DFR is a practical and informative biomarker that independently predicts in-hospital mortality in sepsis, complementing established severity scores. To our knowledge, this is among the first studies to evaluate DFR specifically in septic patients. Our findings suggest that DFR may provide additional value for early risk stratification, but external validation in larger, multicenter cohorts is warranted before its routine implementation.
- 1 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (4) , 630-636
The Prognostic Role of the D-dimer/Fibrinogen Ratio in Predicting In-hospital Mortality among Sepsis Patients
Aims: Dysregulated coagulation and fibrinolysis are central to sepsis pathobiology. This study evaluated the prognostic value of the D-dimer/fibrinogen ratio (DFR) for in-hospital mortality in patients with sepsis. Methods: We analyzed 130 consecutive sepsis patients. The Sepsis-3 criteria were used to establish the diagnosis of sepsis. Demographic and clinical variables, APACHE II, SOFA, D-dimer, fibrinogen, and DFR were recorded at admission. The association between DFR and in-hospital mortality was assessed using multivariable models alongside APACHE II and SOFA. Discrimination was examined with ROC analysis. Results: Non-survivors had higher APACHE II scores, SOFA scores, and DFR than survivors. In multivariable analysis, increasing APACHE II, SOFA, and DFR were each independent predictors of in-hospital mortality. DFR showed high sensitivity and specificity for mortality on ROC analysis. Demographic features did not correlate with survival. Conclusion: DFR is a practical and informative biomarker that independently predicts in-hospital mortality in sepsis, complementing established severity scores. To our knowledge, this is among the first studies to evaluate DFR specifically in septic patients. Our findings suggest that DFR may provide additional value for early risk stratification, but external validation in larger, multicenter cohorts is warranted before its routine implementation.
- Open Access
- 24 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6765
Investigation of the Prognostic Value of Novel Laboratory Indices in Patients with Sepsis in an Intensive Care Unit: A Retrospective Observational Study
Background: This study aimed to evaluate the prognostic value of some novel laboratory indices in intensive care unit (ICU)-hospitalized sepsis patients. Methods: This retrospective, observational study included 400 patients with sepsis. The indices studied were the C-reactive protein/albumin ratio (CAR), hemoglobin, albumin lymphocyte, and platelet (HALP) score, lymphocyte/monocyte ratio (LMR), prognostic nutritional index (PNI), systemic immune inflammatory index (SII), vitamin B12xC-reactive protein index (BCI), systemic inflammatory response index (SIRI), and platelet/lymphocyte ratio (PLR). The predicting effects of these indices in ICU mortality, along with other clinical outcomes, were investigated. Results: The median age of the study population was 73 (18–95) years and 51.6% were males. The ICU mortality rate was 51.7%. Deceased patients with sepsis had an increased age and high APACHE II and SOFA scores compared to the survivors (p < 0.05 for all). In the multivariate logistic regression analysis, age (HR = 1.069, p = 0.038 in Model 1 vs. HR = 1.053, p = 0.001 in Model 2), SOFA score (HR = 2.145, p < 0.001 in Model 1 vs. HR = 1.740, p < 0.001 in Model 2), phosphorus levels (in Model 1, HR = 0.608, p = 0.037), and CAR (in Model 2, HR = 1.012, p = 0.023) were independent associated factors for ICU mortality. According to the ROC analyses, the SOFA (AUC = 0.879, p < 0.001) and APACHE II (AUC = 0.769, p < 0.001) scores showed high accuracy in predicting ICU mortality, while the PNI (AUC = 0.675, p < 0.001), CAR (AUC = 0.609, p < 0.001), and the BCI (AUC = 0.648, p < 0.001) showed limited accuracy. However, the HALP score did not reach a significant level in predicting ICU mortality (p = 0.067). Conclusions: Excluding the HALP score, the new laboratory indices mentioned above may be prognostic markers for predicting clinical outcomes in intensive care units for patients with sepsis. However, these indices need to be supported by larger patient populations.
- 24 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6765
Open AccessInvestigation of the Prognostic Value of Novel Laboratory Indices in Patients with Sepsis in an Intensive Care Unit: A Retrospective Observational Study
Background: This study aimed to evaluate the prognostic value of some novel laboratory indices in intensive care unit (ICU)-hospitalized sepsis patients. Methods: This retrospective, observational study included 400 patients with sepsis. The indices studied were the C-reactive protein/albumin ratio (CAR), hemoglobin, albumin lymphocyte, and platelet (HALP) score, lymphocyte/monocyte ratio (LMR), prognostic nutritional index (PNI), systemic immune inflammatory index (SII), vitamin B12xC-reactive protein index (BCI), systemic inflammatory response index (SIRI), and platelet/lymphocyte ratio (PLR). The predicting effects of these indices in ICU mortality, along with other clinical outcomes, were investigated. Results: The median age of the study population was 73 (18–95) years and 51.6% were males. The ICU mortality rate was 51.7%. Deceased patients with sepsis had an increased age and high APACHE II and SOFA scores compared to the survivors (p < 0.05 for all). In the multivariate logistic regression analysis, age (HR = 1.069, p = 0.038 in Model 1 vs. HR = 1.053, p = 0.001 in Model 2), SOFA score (HR = 2.145, p < 0.001 in Model 1 vs. HR = 1.740, p < 0.001 in Model 2), phosphorus levels (in Model 1, HR = 0.608, p = 0.037), and CAR (in Model 2, HR = 1.012, p = 0.023) were independent associated factors for ICU mortality. According to the ROC analyses, the SOFA (AUC = 0.879, p < 0.001) and APACHE II (AUC = 0.769, p < 0.001) scores showed high accuracy in predicting ICU mortality, while the PNI (AUC = 0.675, p < 0.001), CAR (AUC = 0.609, p < 0.001), and the BCI (AUC = 0.648, p < 0.001) showed limited accuracy. However, the HALP score did not reach a significant level in predicting ICU mortality (p = 0.067). Conclusions: Excluding the HALP score, the new laboratory indices mentioned above may be prognostic markers for predicting clinical outcomes in intensive care units for patients with sepsis. However, these indices need to be supported by larger patient populations.
- Open Access
- 12 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331962
New frontiers in radiologic interpretation: evaluating the effectiveness of large language models in pneumothorax diagnosis
Background: This study evaluates the diagnostic performance of three multimodal large language models (LLMs)—ChatGPT-4o, Gemini 2.0, and Claude 3.5—in identifying pneumothorax from chest radiographs. Methods: In this retrospective analysis, 172 pneumothorax cases (148 patients aged >12 years, 24 patients aged ≤12 years) with both chest radiographs and confirmatory thoracic CT were included from a tertiary emergency department. Patients were categorized by age and pneumothorax size (small/large). Each radiograph was presented to all three LLMs accompanied by basic symptoms (dyspnea or chest pain), with each model analyzing each image three times. Diagnostic accuracy was evaluated using overall accuracy (all three responses correct), strict accuracy (≥2 responses correct), and ideal accuracy (≥1 response correct), alongside response consistency assessment using Fleiss’ Kappa. Results: In patients older than 12 years, ChatGPT-4o demonstrated the highest overall accuracy (69.6%), followed by Claude 3.5 (64.9%) and Gemini 2.0 (57.4%). Performance was significantly poorer in pediatric patients across all models (20.8%, 12.5%, and 20.8%, respectively). For large pneumothorax in adults, ChatGPT-4o showed significantly higher accuracy compared to small pneumothorax (81.6% vs. 42.2%; p < 0.001). Regarding consistency, Gemini 2.0 demonstrated excellent reliability for large pneumothorax (Kappa = 1.00), while Claude 3.5 showed moderate consistency across both pneumothorax sizes. Conclusion: This study, the first to evaluate these three current multimodal LLMs in pneumothorax identification across different age groups, demonstrates promising results for potential clinical applications, particularly for adult patients with large pneumothorax. However, performance limitations in pediatric cases and with small pneumothoraces highlight the need for further validation before clinical implementation.
- 12 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331962
Open AccessNew frontiers in radiologic interpretation: evaluating the effectiveness of large language models in pneumothorax diagnosis
Background: This study evaluates the diagnostic performance of three multimodal large language models (LLMs)—ChatGPT-4o, Gemini 2.0, and Claude 3.5—in identifying pneumothorax from chest radiographs. Methods: In this retrospective analysis, 172 pneumothorax cases (148 patients aged >12 years, 24 patients aged ≤12 years) with both chest radiographs and confirmatory thoracic CT were included from a tertiary emergency department. Patients were categorized by age and pneumothorax size (small/large). Each radiograph was presented to all three LLMs accompanied by basic symptoms (dyspnea or chest pain), with each model analyzing each image three times. Diagnostic accuracy was evaluated using overall accuracy (all three responses correct), strict accuracy (≥2 responses correct), and ideal accuracy (≥1 response correct), alongside response consistency assessment using Fleiss’ Kappa. Results: In patients older than 12 years, ChatGPT-4o demonstrated the highest overall accuracy (69.6%), followed by Claude 3.5 (64.9%) and Gemini 2.0 (57.4%). Performance was significantly poorer in pediatric patients across all models (20.8%, 12.5%, and 20.8%, respectively). For large pneumothorax in adults, ChatGPT-4o showed significantly higher accuracy compared to small pneumothorax (81.6% vs. 42.2%; p < 0.001). Regarding consistency, Gemini 2.0 demonstrated excellent reliability for large pneumothorax (Kappa = 1.00), while Claude 3.5 showed moderate consistency across both pneumothorax sizes. Conclusion: This study, the first to evaluate these three current multimodal LLMs in pneumothorax identification across different age groups, demonstrates promising results for potential clinical applications, particularly for adult patients with large pneumothorax. However, performance limitations in pediatric cases and with small pneumothoraces highlight the need for further validation before clinical implementation.